Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 79
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary References AAMC (Association of American Medical Colleges). 1998. AAMC Data Book: Statistical Information Related to Medical Schools and Teaching Hospitals, Table D4. Washington, D.C.: AAMC. ASTHO (Association of State and Territorial Health Officials). 1995. Managed Care Monograph Series: Introduction to Managed Care for State Health Agencies. ASTHO Primary Care Project, Bureau of Primary Health Care. Washington, D.C.: ASTHO. Ballow, C.H., and J.J. Schentag. 1992. Trends in antibiotic utilization and bacterial resistance: Report of the NNRSG. Diagnostic Microbiology and Infectious Diseases 15:37S–42S. Barden, L.S., S.F. Dowell, B. Schwartz, and C. Lackey. 1998. Current attitudes regarding use of antimicrobial agents: Results from physicians' and parents' focus group discussions. Clinical Pediatrics 37:665–671. CDC (Centers for Disease Control and Prevention). 1995. Prevention and managed care: Opportunities for managed care organizations, purchasers of health care, and public health agencies. Morbidity and Mortality Weekly Report 44(RR-14):1–12. CDC. 1998. Adoption of hospital policies for prevention of perinatal Group B streptococcal disease—United States, 1997. Morbidity and Mortality Weekly Report 47(32): 665–670. Chernew, M., A.M. Fendrick, and R.A. Hirth. 1997. Managed care and medical technology: Implications for cost growth . Health Affairs 16:196–206. DVA (U.S. Department of Veterans Affairs), Office of Research and Development. 1997. Improving Health Care for Veterans. Annual Report . Washington, D.C.: DVA. DVA, Veterans Health Administration. 1998. Journey of Change II: Annual Report and Strategic Forecast. Washington, D.C.: DVA. Garber, A.M., M.C. Weinstein, G.W. Torrance, and M.S. Kamlet. 1996. Theoretical Foundations of Cost-Effectiveness Analysis. New York: Oxford University Press. Horn, S. D., P.D. Sharkey, D. M. Tracy, C.E. Horn, B. James, and F. Goodwin. 1996. Intended and unintended consequences of HMO cost-containment strategies: Results
OCR for page 80
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary from the Managed Care Outcomes project. American Journal of Managed Care 2(3):253–264. Hueston, W.J., A.G. Mainous, N. Brauer, and J. Mercuri. 1997. Evaluation and treatment of respiratory infections: Does managed care make a difference? Journal of Family Practice 44:261–265. IOM (Institute of Medicine). 1992. Emerging Infections: Microbial Threats to Health in the United States. Washington, D.C.: National Academy Press. IOM. 1997a. Managing Managed Care: Quality Improvements in Behavioral Health. M. Edmunds, R. Frank, M. Hogan, D. McCarty, R. Robinson-Beale, and C. Weisner, eds. Washington, D.C.: National Academy Press. IOM. 1997b. Orphans and Incentives: Developing Technologies to Address Emerging Infections. Workshop Report. Washington, D.C.: National Academy Press. IOM. 1998. Antimicrobial Resistance: Issues and Options. Workshop Report. Washington, D.C.: National Academy Press. IOM. 1999. Extending Medicare Reimbursement in Clinical Trials. Washington, D.C.: National Academy Press. Kizer, K.W. 1997. The veterans healthcare system: Preparing for the twenty-first century. Hospital and Health Services Administration 42(3):283–298. Kizer, K.W. 1999. The new VA: A national laboratory for health care quality management. American Journal of Medical Quality 14(1):3–20. Kralovic, S.M., G.A. Roselle, L.H. Danko, L.A. Simbartl, and K.W. Kizer. 1999. Hepatitis C virus antibody (HCAb) positivity in Department of Veterans Affairs (VA) facilities. In 9th Annual Meeting of the Society of Healthcare Epidemiology of America, April 18–20, 1999. Kunzi, S.G. 1999. National drug formularies. Pharmaceutical Executive 19(4):80–90. Kuttner, R. 1998. Must good HMOs go bad? First of two parts: The commercialization of prepaid group health care. New England Journal of Medicine 338:1558–1563. Levine, V.R. 1998. Epidemiology of AIDS and tuberculosis among United States veterans. International Journal of Tuberculosis and Lung Disease 2(5):405–412. Levy, R.A. and D.L. Cocks. 1996. Component Management Fails to Save Health Care System Costs: The Case of Restrictive Formularies. Reston, Va.: National Pharmaceutical Council. Miller, R.H., and H.S. Luft. 1994. Managed care plan performance since 1980: A literature analysis. Journal of the American Medical Association 19:1512–1519. Moy, E., A.J. Mazzaschi, R.J. Levin, D.A. Blake, and P.F. Griner. 1997. Relationship between National Institutes of Health research awards to US medical schools and managed care market penetration. Journal of the American Medical Association 278(3):217–221. Paladino, J.A., H.F. Sperry, J.M. Backes, J.A. Gelber, D.A. Serrianne, T.J. Cumbo, and J.J. Schentag. 1991. Clinical and economic evaluations of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. American Journal of Medicine 91:462–470. Rifenburg, R.P., S.C. Hanson, J.A. Tuttle, J.A. Paladino, and J.J. Schentag. 1996. Use of benchmarking techniques to analyze the strategies hospitals use to control antibiotic expenditures. American Journal of Health-System Pharmacy 53:2054–2062. Roselle, G.A., S.M. Kralovic, S.E. Dane, L.A. Simbartl, L.H. Danko, and K.W. Kizer. 1999. A Department of Veterans Affairs computerized national surveillance system. In 9th Annual Meeting of the Society for Healthcare Epidemiology of America, April 18–20, 1999.
OCR for page 81
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary Rosenbaum, S., B.M. Smith, P.Shin, M.H. Zakheim, K. Shaw, C.A. Sonosky, and L. Repasch. 1997. Negotiating the New Health Care System: A Nationwide Study of Medicaid Managed Care Contracts, Vol. 1. Washington, D.C.: George Washington University Medical Center. Sachs, G. 1997. Quest Diagnostics Incorporated.' A Turnaround Story . New York: Goldman Sachs Research. Sands, K., G. Vineyard, J. Livingston, C. Christiansen, and R. Platt. 1999. Efficient identification of postdischarge surgical site infections: Use of automated pharmacy dispensing information, administrative data, and medical record information. Journal of Infectious Diseases 179(2):434–441. Sands, K., G. Vineyard, and R. Platt. 1996. Surgical site infections occurring after hospital discharge. Journal of Infectious Diseases 173(4):963–970. Schentag, J.J., J.R. Cart, M.H. Adelman, M.C. Birmingham, G.S. Zimmer, and J.A. Paladino. 1996. Formulary management versus disease management. Infectious Diseases in Clinical Practice 5(Suppl. 1):1–6. Schentag, J.J., J.M. Hyatt, J.R. Carr, J.A. Paladino, M.C. Birmingham, G.S. Zimmer, and T.J. Cumbo. 1998. Genesis of methicillin resistant Staphylococcus aureus (MRSA), how treatment of MRSA infection has selected for VREF, and the importance of antibiotic management and infection control. Clinical Infectious Diseases 26:1204–1214. Schuchat, A. 1999. Group B streptococcus. Lancet 353:51–56. Wilson, N.J., and K.W. Kizer. 1997. The VA health care system: An unrecognized national safety net. Health Affairs. 16(4):200–204.
OCR for page 82
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary This page in the original is blank.
Representative terms from entire chapter: